Good Samaritan Society - Bottineau | |
725 E 10th St, Bottineau, North Dakota 58318 | |
(701) 228-3796 | |
Name | Good Samaritan Society - Bottineau |
---|---|
Location | 725 E 10th St, Bottineau, North Dakota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 48 |
Occupancy Rate | 65.83% |
Medicare ID (CCN) | 355093 |
Legal Business Name | The Evangelical Lutheran Good Samaritan Society |
Ownership Type | Non Profit - Corporation |
NPI Number | 1407837263 |
Organization Name | THE EVANGELICAL LUTHERAN GOOD SAMARITAN SOCIETY |
Doing Business As | GOOD SAMARITAN SOCIETY - BOTTINEAU |
Address | 725 10th St E, Bottineau, ND 58318 |
Phone Number | 701-228-3796 |
News Archive
No matter what climate you live in, you're more likely to die of heart-related issues in the winter, according to research presented at the American Heart Association's Scientific Sessions 2012.
The only way to protect against HIV and unintended pregnancy today is the condom. It's an effective technology, but not appropriate or popular in all situations.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its expanded offering of Powerlink® stent graft products. The approval covers 31 new sizes of Powerlink® main body bifurcated, proximal extension, and limb extension stent grafts that increase the system's addressable patient population by 5% to 10%.
Even though older patients with colon cancer are less likely to receive chemotherapy following surgery because of concerns of adverse events, new research indicates that when they do receive this treatment, it is less toxic and of shorter duration than therapy younger patients receive, and older patients experience fewer adverse events, according to a study in the March 17 issue of JAMA, a theme issue on cancer.
The American Gastroenterological Association (AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry — which seeks to compare laparoscopic surgery to an incisionless procedure to treat gastroesophageal reflux disease (GERD) — have successfully undergone treatment.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
No matter what climate you live in, you're more likely to die of heart-related issues in the winter, according to research presented at the American Heart Association's Scientific Sessions 2012.
The only way to protect against HIV and unintended pregnancy today is the condom. It's an effective technology, but not appropriate or popular in all situations.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its expanded offering of Powerlink® stent graft products. The approval covers 31 new sizes of Powerlink® main body bifurcated, proximal extension, and limb extension stent grafts that increase the system's addressable patient population by 5% to 10%.
Even though older patients with colon cancer are less likely to receive chemotherapy following surgery because of concerns of adverse events, new research indicates that when they do receive this treatment, it is less toxic and of shorter duration than therapy younger patients receive, and older patients experience fewer adverse events, according to a study in the March 17 issue of JAMA, a theme issue on cancer.
The American Gastroenterological Association (AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry — which seeks to compare laparoscopic surgery to an incisionless procedure to treat gastroesophageal reflux disease (GERD) — have successfully undergone treatment.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 24.43 | 14.46 |
Percentage of long-stay residents who lose too much weight | 15.65 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 48.72 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.82 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.71 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 11.02 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 7.46 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 28.91 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94.44 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 21.37 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.43 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.49 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.48 | 95.98 |
Percentage of short-stay residents who made improvements in function | 0 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.37 | 82.93 |
News Archive
No matter what climate you live in, you're more likely to die of heart-related issues in the winter, according to research presented at the American Heart Association's Scientific Sessions 2012.
The only way to protect against HIV and unintended pregnancy today is the condom. It's an effective technology, but not appropriate or popular in all situations.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its expanded offering of Powerlink® stent graft products. The approval covers 31 new sizes of Powerlink® main body bifurcated, proximal extension, and limb extension stent grafts that increase the system's addressable patient population by 5% to 10%.
Even though older patients with colon cancer are less likely to receive chemotherapy following surgery because of concerns of adverse events, new research indicates that when they do receive this treatment, it is less toxic and of shorter duration than therapy younger patients receive, and older patients experience fewer adverse events, according to a study in the March 17 issue of JAMA, a theme issue on cancer.
The American Gastroenterological Association (AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry — which seeks to compare laparoscopic surgery to an incisionless procedure to treat gastroesophageal reflux disease (GERD) — have successfully undergone treatment.
› Verified 2 days ago
Good Samaritan Society - Bottineau Location: 725 E 10th St, Bottineau, North Dakota 58318 Phone: (701) 228-3796 |